2023 Form 5500 filing — Hematology-Oncology Associates Of Central New York, P.C. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241007121113NAL0031684274001) for Hematology-Oncology Associates Of Central New York, P.C. 401(K) Plan, reported by Hematology-Oncology Associates Of Central New York, P.C. under EIN 16-1184100 and plan number 002. It reports 462 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241007121113NAL0031684274001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Hematology-Oncology Associates Of Central New York, P.C.
- EIN
- 16-1184100
- Plan number
- 002
- Location
- East Syracuse, NY
- Participants
- 462
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $63,617,228
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $63,617,228
- Employer contributions
- $1,900,094
- Participant contributions
- $2,347,931
- Total income / additions
- $11,114,184
- Benefits paid
- $1,838,981
- Administrative expenses
- $33,747
- Total expenses
- $1,881,348
- Net increase / (decrease)
- $9,232,836
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Hnp Capital, LLC | NONE | $13,140 | not reported in the loaded dataset |
| The Vanguard Group, Inc. | NONE | $12,839 | $0 |
| Courier Capital. | NONE | $6,708 | not reported in the loaded dataset |